Annias Immunotherapeutics




Reiner Laus

Duke Inventor(s):

John Sampson, Duane Mitchell, Weihua Xie, Kristen Batich, Michael Gunn

Cancer immunotherapy targeting CMV

Annias Immunotherapeutics, Inc. is a clinical stage immuno-oncology company focused on the development of novel immunotherapeutic approaches to the treatment of cancers that containing Cytomegalovirus (CMV). The company’s approach is based on a patented and proprietary immunotherapeutic platform, discovered at Duke University, which harnesses the body’s immune system to recognize, attack and destroy tumor cells containing CMV.